Eli Lilly and Company (NYSE:LLY) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2023 Earnings Conference Call.
Source: insidermonkey.com
Page 19 - Dave Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dave Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dave Ricks Today - Breaking & Trending Today
Positive Alzheimer's data pushes Eli Lilly to all-time high, brightens our outlook
Eli Lilly's experimental Alzheimer's drug slowed disease progression in a large-scale study.
Source: cnbc.com
Eli Lilly drug slows Alzheimer's disease, study finds
The success means patients and their caregivers could soon have another therapy shown to slow the disease alongside Leqembi — made by Cambridge biotech Biogen and Japanese drug maker Eisai — which was approved in January.
Source: bostonglobe.com
Eli Lilly says experimental drug slows decline from Alzheimer's – Indianapolis Business Journal
If approved, Donanemab has annual multi-billion-dollar sales potential. Lilly shares rose 6% in early-afternoon trading.
Source: ibj.com
Eli Lilly drug slows Alzheimer's disease, study finds
Eli Lilly Co. s shares climbed in premarket trading after its experimental drug for Alzheimer s slowed the progress of the disease in a final stage...
Source: thepeninsulaqatar.com